Teladoc Health Inc. (TDOC) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Teladoc Health Inc. (TDOC) carries a Roarable Rating of C- (Hold) with 60/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How TDOC Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $2.53B | 44% | -10.4% | -$200.3M | $285.5M | -16.4% |
| FY 2024 | $2.57B | 44% | -39.7% | -$1.00B | $282.9M | -45% |
| FY 2023 | $2.60B | 44% | -9.6% | -$220.4M | $232.9M | -10.4% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring TDOC)
- ✓Live walkthrough of TDOC's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
TDOC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -1.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on TDOC today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for TDOC. Explore sector supply chains on /butterfly.
TDOC Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Teladoc Health Inc. (TDOC)?
In FY 2025 (10-K), TDOC converted $2.5B of revenue into a 44% gross margin, 0% operating margin, and $285.5M in free cash flow (11.3% FCF margin).